ArticleCancer chemotherapy and pharmacology2021

A phase 1, open-label, drug-drug interaction study of rucaparib with rosuvastatin and oral contraceptives in patients with advanced solid tumors.

Mingxiang Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.